| Autor: |
Yu-Chen, Enya Chen, Melinda, Burgess, Sally, Mapp, Peter, Mollee, Devinder, Gill, Antje, Blumenthal, Nicholas A, Saunders |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Leukemia. 34(2) |
| ISSN: |
1476-5551 |
| Popis: |
Fcγ receptor (FcγR) signalling in monocyte derived macrophages from chronic lymphocytic leukaemia (CLL) patients is poorly understood. This signalling pathway is the key determinant of the ability of the macrophages to respond to therapeutic antibodies in current clinical use for CLL. Muted FcγR signalling activity accompanies disease progression and results in resistance to therapeutic antibodies. The molecular mechanisms controlling FcγR signalling and resistance are unknown. Here, we demonstrate that the class I phosphoinositide 3-kinase (PI3K) catalytic subunit p110δ is essential for CLL-derived macrophages to respond to therapeutic antibodies. Inhibition of p110δ in the macrophages reduces FcγR-mediated antibody immune responses. Surprisingly, our studies indicated that FcγR downstream signalling is independent of SYK and BTK activity. Thus, we show that FcγR antibody responses occur via a previously unidentified p110δ-dependent pathway, which is independent of the previously described SYK/BTK activation pathway. These data provide novel insights into the effectors of antibody responses. Our data also provide mechanistic insights into therapy resistance in CLL. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink